- call +1-201-465-4211
- email sales@mrinsights.biz
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Scope of the Report:
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.
The worldwide market for Oral Vaccines is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 3010 million US$ in 2024, from 2010 million US$ in 2019, according to a new study.
This report focuses on the Oral Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Market Segment by Applications, can be divided into
Public
Private
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines in 2017 and 2018.
Chapter 3, the Oral Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oral Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Public
1.3.2 Private
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Oral Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Oral Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Oral Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Lanzhou Institute
2.4.1 Business Overview
2.4.2 Oral Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Serum Institute
2.5.1 Business Overview
2.5.2 Oral Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Valneva
2.6.1 Business Overview
2.6.2 Oral Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Valneva Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Shanghai United Cell
2.7.1 Business Overview
2.7.2 Oral Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bibcol
2.8.1 Business Overview
2.8.2 Oral Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bibcol Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 PaxVax
2.9.1 Business Overview
2.9.2 Oral Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Vabiotech
2.10.1 Business Overview
2.10.2 Oral Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Tiantan Biological
2.11.1 Business Overview
2.11.2 Oral Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 EuBiologics
2.12.1 Business Overview
2.12.2 Oral Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Panacea Biotec Ltd
2.13.1 Business Overview
2.13.2 Oral Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Bio-Med
2.14.1 Business Overview
2.14.2 Oral Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Business Overview
2.15.2 Oral Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oral Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Oral Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Oral Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Oral Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Oral Vaccines Market Analysis by Regions
4.1 Global Oral Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Oral Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Oral Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Oral Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Oral Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Oral Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Oral Vaccines Sales and Growth Rate (2014-2019)
5 North America Oral Vaccines by Country
5.1 North America Oral Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Oral Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Oral Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Oral Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Oral Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Oral Vaccines Sales and Growth Rate (2014-2019)
6 Europe Oral Vaccines by Country
6.1 Europe Oral Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Oral Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Oral Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Oral Vaccines Sales and Growth Rate (2014-2019)
6.4 France Oral Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Oral Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Oral Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Oral Vaccines by Country
7.1 Asia-Pacific Oral Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Oral Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Oral Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Oral Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Oral Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Oral Vaccines Sales and Growth Rate (2014-2019)
7.5 India Oral Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Oral Vaccines Sales and Growth Rate (2014-2019)
8 South America Oral Vaccines by Country
8.1 South America Oral Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Oral Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Oral Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Oral Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Oral Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Oral Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Oral Vaccines by Countries
9.1 Middle East and Africa Oral Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Oral Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Oral Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Oral Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Oral Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Oral Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Oral Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Oral Vaccines Sales and Growth Rate (2014-2019)
10 Global Oral Vaccines Market Segment by Type
10.1 Global Oral Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Oral Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Oral Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Rotavirus Vaccine Sales Growth and Price
10.2.1 Global Rotavirus Vaccine Sales Growth (2014-2019)
10.2.2 Global Rotavirus Vaccine Price (2014-2019)
10.3 Cholera Vaccine Sales Growth and Price
10.3.1 Global Cholera Vaccine Sales Growth (2014-2019)
10.3.2 Global Cholera Vaccine Price (2014-2019)
10.4 Oral Polio Vaccine Sales Growth and Price
10.4.1 Global Oral Polio Vaccine Sales Growth (2014-2019)
10.4.2 Global Oral Polio Vaccine Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Oral Vaccines Market Segment by Application
11.1 Global Oral Vaccines Sales Market Share by Application (2014-2019)
11.2 Public Sales Growth (2014-2019)
11.3 Private Sales Growth (2014-2019)
12 Oral Vaccines Market Forecast (2019-2024)
12.1 Global Oral Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Oral Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Oral Vaccines Market Forecast (2019-2024)
12.2.2 Europe Oral Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Oral Vaccines Market Forecast (2019-2024)
12.2.4 South America Oral Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Oral Vaccines Market Forecast (2019-2024)
12.3 Oral Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Oral Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Oral Vaccines Market Share Forecast by Type (2019-2024)
12.4 Oral Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Oral Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Oral Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oral Vaccines Picture
Table Product Specifications of Oral Vaccines
Figure Global Sales Market Share of Oral Vaccines by Types in 2018
Table Oral Vaccin
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
